Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug ...

The parents of a "miracle boy" who died suddenly from a rare form of meningitis have said they are working to raise awareness ...

He added that IMD leads to death in a matter of hours due to its rapid course of progression, including an average incubation ...

The US FDA has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive meningococcal disease.

For patients transitioning from rituximab to ravulizumab, meningococcal vaccination can be safely done within 6 months after stopping rituximab.

The immunization schedule protects against 14 potentially serious diseases before a child’s second birthday, as recommended ...

Such herd immunity effects have been demonstrated following the introduction of meningococcal serogroup C conjugate (MCC) vaccines, with reductions in disease attack rates in unimmunized ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

MenACWY-CRM was supplied in 2 vials: 1 vial of lyophilized powder containing 10 μg of MenA oligosaccharide conjugated to CRM 197 and a second liquid conjugate vaccine component containing 5 μg ...

In this piece, we include reporting tips, how vaccine side effects are tracked in the U.S., and what research shows about the ...

The editorial board of the New York Post is urging Health and Human Services Secretary Robert F. Kennedy Jr. to clarify that ...

Vaccine helps protect against the A, B, C, W, and Y serogroups of Neisseria meningitidis. (HealthDay News) — The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A ...